Fabrizia Urbinati
Critic · DISC type CDr. Fabrizia Urbinati is the Director of Cell and Gene Therapies at Stanford Universitys Innovative Medicines Accelerator. With over 15 years of expertise, she specializes in translational research, focusing on developing lentiviral and AAV gene therapies for conditions like sickle cell disease and neuromuscular disorders. She earned her PhD from the University of Modena and Reggio Emilia.
Dr. Urbinati is passionate about bridging the gap between academic discovery and clinical application to create cures for patients. She has a strong focus on mentoring the next generation of scientists, evidenced by her active sharing of postdoctoral research opportunities.
She has extensive experience taking therapies from preclinical stages to clinical trials, including navigating cell manufacturing and regulatory processes.
Read the full overview →How Fabrizia shows up
Unless the value is proven by data, they are unlikely to value fancy features. It is very likely that they will negotiate pricing or other important terms. They like to take decisions independently and do not seek others' support often.
Topics Fabrizia cares about
Work history
Media appearances
DISC profile (public)
Calculativeness (C)
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Other Stanford University Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.